Zobrazeno 1 - 10 of 62 pro vyhledávání: '"M. Van der Aalst"'
1
Akademický článek
Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada.
Autor: Kevin Ten Haaf, Martin C Tammemägi, Susan J Bondy, Carlijn M van der Aalst, Sumei Gu, S Elizabeth McGregor, Garth Nicholas, Harry J de Koning, Lawrence F Paszat
Publikováno v: PLoS Medicine, Vol 14, Iss 2, p e1002225 (2017)
BACKGROUND:The National Lung Screening Trial (NLST) results indicate that computed tomography (CT) lung cancer screening for current and former smokers with three annual screens can be cost-effective in a trial setting. However, the cost-effectivenes
Externí odkaz: https://doaj.org/article/23118810297e42b8808708714002ed8a
Zobrazit plný text záznamu
2
Early detection of obstructive coronary artery disease in the asymptomatic high-risk population: objectives and study design of the EARLY-SYNERGY trial
Autor: Daan Ties, Paulien van Dorp, Gabija Pundziute, Carlijn M. van der Aalst, Jan Willem C. Gratama, Richard L. Braam, Dirkjan Kuijpers, Daniël D. Lubbers, Ivo A.C. van der Bilt, B. Daan Westenbrink, Martijn J. Oude Wolcherink, Carine J.M. Doggen, Ivana Išgum, Robin Nijveldt, Harry J. de Koning, Rozemarijn Vliegenthart, Matthijs Oudkerk, Pim van der Harst
Publikováno v: American Heart Journal, 246, 166-177. MOSBY-ELSEVIER
American Heart Journal, 246, pp. 166-177
American Heart Journal, 246, 166-177. Mosby Inc.
American heart journal, 246, 166-177. Mosby Inc.
American Heart Journal, 246, 166-177
Contains fulltext : 249975.pdf (Publisher’s version ) (Open Access) BACKGROUND: Coronary artery disease (CAD) burden for society is expected to steeply increase over the next decade. Improved feasibility and efficiency of preventive strategies is n
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c62793eb74981edeed318d6b89ce43c1
https://research.rug.nl/en/publications/957edcce-9601-493a-b261-b05363377d35
Zobrazit plný text záznamu
3
Anti-tumor necrosis factor therapy in patients with inflammatory bowel disease; comorbidity, not patient age, is a predictor of severe adverse events
Autor: Bas A. C. van Tuyl, Marieke Pierik, Vera E. R. Asscher, P W Jeroen Maljaars, Bas Oldenburg, Anniek M. van der Aalst, Andrea E. van der Meulen-de Jong, Dutch Icc, Eelco C. Brand, Nofel Mahmmod, Karen van der Aalst, Herma H. Fidder, Quirine M.J. van der Vliet
Publikováno v: International Journal of Colorectal Disease
International Journal of Colorectal Disease, 35(12), 2331-2338. SPRINGER
International Journal of Colorectal Disease, 35(12), 2331-2338. Springer, Cham
Purpose To assess safety and effectiveness of anti-tumor necrosis factor (anti-TNF) therapy in IBD patients ≥ 60 years. Methods Ninety IBD patients ≥ 60 years at initiation of anti-TNF therapy, 145 IBD patients ≥ 60 years without anti-TNF thera
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e38666bfc82218187a355af8fde9b48b
https://cris.maastrichtuniversity.nl/en/publications/e92f6606-f495-47b1-9535-c069cf7f826d
Zobrazit plný text záznamu
4
Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial
Autor: Johny Verschakelen, Peter M. A. van Ooijen, Uraujh Yousaf-Khan, Michael A. den Bakker, Harry J.M. Groen, Mathias Prokop, Susan van 't Westeinde, Pim A. de Jong, Nanda Horeweg, Joachim G.J.V. Aerts, Kevin ten Haaf, Kristiaan Nackaerts, Willem P.Th.M. Mali, Jan-Willem J. Lammers, Matthijs Oudkerk, Firdaus A. A. Mohamed Hoesein, Marjolein A Heuvelmans, Carla Weenink, Ernst Th. Scholten, Harry J. de Koning, Erik Thunnissen, Carlijn M. van der Aalst, Rozemarijn Vliegenthart, Joan Walter
Publikováno v: The New England journal of medicine, 382(6), 503-513. Massachusetts Medical Society
The New England journal of medicine, 382(6), 503. Massachussetts Medical Society
The New England Journal of Medicine, 382, 503-513
New England Journal of Medicine, 382(6), 503-513. MASSACHUSETTS MEDICAL SOC
The New England Journal of Medicine, 382, 6, pp. 503-513
New England Journal of Medicine, 382(6), 503-513. Massachussetts Medical Society
De Koning, H J, Van Der Aalst, C M, De Jong, P A, Scholten, E T, Nackaerts, K, Heuvelmans, M A, Lammers, J W J, Weenink, C, Yousaf-Khan, U, Horeweg, N, Van'T Westeinde, S, Prokop, M, Mali, W P, Mohamed Hoesein, F A A, Van Ooijen, P M A, Aerts, J G J V, Den Bakker, M A, Thunnissen, E, Verschakelen, J, Vliegenthart, R, Walter, J E, Ten Haaf, K, Groen, H J M & Oudkerk, M 2020, ' Reduced lung-cancer mortality with volume CT screening in a randomized trial ', New England Journal of Medicine, vol. 382, no. 6, pp. 503-513 . https://doi.org/10.1056/NEJMoa1911793
Contains fulltext : 219680.pdf (Publisher’s version ) (Open Access) BACKGROUND: There are limited data from randomized trials regarding whether volume-based, low-dose computed tomographic (CT) screening can reduce lung-cancer mortality among male f
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd99e923f4a48e7f5f0e31e0ea1073ea
https://hdl.handle.net/2066/219680
Zobrazit plný text záznamu
5
Screening for cardiovascular disease risk using traditional risk factor assessment or coronary artery calcium scoring: The ROBINSCA trial
Autor: Harry J. de Koning, Jeanine E. Roeters van Lennep, Dirkjan Kuijpers, Richard L. Braam, Jan Willem C. Gratama, Paul R. M. van Dijkman, Matthijs Oudkerk, Rozemarijn Vliegenthart, Pim van der Harst, Henk J Adriaansen, Marleen Vonder, Rykel van Bruggen, Carlijn M. van der Aalst, Sabine J A M Denissen
Publikováno v: European Heart Journal-Cardiovascular Imaging, 21(11), 1216-1224. Oxford University Press
European Heart Journal-Cardiovascular Imaging, 21(11), 1216-1224. OXFORD UNIV PRESS
European Heart Journal Cardiovascular Imaging, 21(11), 1216-1224. Oxford University Press
Aims Screening for a high cardiovascular disease (CVD) risk followed by preventive treatment can potentially reduce coronary heart disease-related morbidity and mortality. ROBINSCA (Risk Or Benefit IN Screening for CArdiovascular disease) is a popula
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9671baacbeacec4d98e6eac3560f2e69
https://pure.eur.nl/en/publications/45a1350f-cd08-4976-a2cd-59edd1d8798c
Zobrazit plný text záznamu
6
Screening for coronary artery calciumin a high-risk population: the ROBINSCA trial
Autor: Harry J. de Koning, Carlijn M. van der Aalst, Jan Willem C. Gratama, Paul R. M. van Dijkman, Rozemarijn Vliegenthart, Jeanine E. Roeters van Lennep, Sabine J A M Denissen, Dirkjan Kuijpers, Matthijs Oudkerk, Pim van der Harst, Richard L. Braam, Marleen Vonder, Henk J Adriaansen
Publikováno v: European Journal of Preventive Cardiology, 28(10), 1155-1159. SAGE Publications Ltd
European Journal of Preventive Cardiology, 281(10), 1155-1159. SAGE PUBLICATIONS LTD
European journal of preventive cardiology, 28(10):2047487320932263, 1155-1159. SAGE Publications Inc.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbdf74c80e821e6d2eb25ba8694799b7
https://doi.org/10.1177/2047487320932263
Zobrazit plný text záznamu
9
Persisting new nodules in incidence rounds of the NELSON CT lung cancer screening study
Autor: Peter M. A. van Ooijen, Uraujh Yousaf-Khan, Kevin ten Haaf, Harry J. de Koning, Carlijn M. van der Aalst, Matthijs Oudkerk, Marjolein A Heuvelmans, Geertruida H. de Bock, Harry J.M. Groen, Rozemarijn Vliegenthart, Joan Walter, Kristiaan Nackaerts
Publikováno v: Thorax, 74(3), 247-253. BMJ Publishing Group
Thorax, 74(3), 247-253. BMJ PUBLISHING GROUP
BackgroundThe US guidelines recommend low-dose CT (LDCT) lung cancer screening for high-risk individuals. New solid nodules after baseline screening are common and have a high lung cancer probability. Currently, no evidence exists concerning the risk
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a2347a2d0783baf3235fc856794bf95
https://doi.org/10.1136/thoraxjnl-2018-212152
Zobrazit plný text záznamu
10
Implementation of lung cancer screening: what are the main issues?
Autor: Carlijn M. van der Aalst, Kevin ten Haaf, Harry J. de Koning
Publikováno v: Translational Lung Cancer Research, 10(2), 1050-1063. Society for Translational Medicine (STM)
Translational Lung Cancer Research
Transl Lung Cancer Res
Two large-scale RCTs have shown computed tomography (CT) lung cancer screening to be efficacious in reducing lung cancer mortality (8-24% in men, 26-59% in women). However, lung cancer screening implicitly means personalised and risk-based approaches
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0c6db7a79e13d8f7f29075a60b5a358
https://pure.eur.nl/en/publications/b2519768-3ae6-41c7-8cc8-1f36af97151b
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje